Correlation Between Phio Pharmaceuticals and BioLineRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and BioLineRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and BioLineRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and BioLineRx, you can compare the effects of market volatilities on Phio Pharmaceuticals and BioLineRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of BioLineRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and BioLineRx.

Diversification Opportunities for Phio Pharmaceuticals and BioLineRx

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between Phio and BioLineRx is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and BioLineRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLineRx and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with BioLineRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLineRx has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and BioLineRx go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and BioLineRx

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the BioLineRx. In addition to that, Phio Pharmaceuticals is 1.43 times more volatile than BioLineRx. It trades about -0.04 of its total potential returns per unit of risk. BioLineRx is currently generating about 0.0 per unit of volatility. If you would invest  68.00  in BioLineRx on August 27, 2024 and sell it today you would lose (40.00) from holding BioLineRx or give up 58.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  BioLineRx

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
BioLineRx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLineRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Phio Pharmaceuticals and BioLineRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and BioLineRx

The main advantage of trading using opposite Phio Pharmaceuticals and BioLineRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, BioLineRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLineRx will offset losses from the drop in BioLineRx's long position.
The idea behind Phio Pharmaceuticals Corp and BioLineRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals